Rapid Rituximab Infusion at 90-minute Among Non-Hodgkin Lymphoma
NCT01482754
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Non Hodgkin Lymphoma
Interventions
DRUG:
Rituximab (Mabthera®, Roche Pty Ltd, Basel, Switzerland)
Sponsor
National University Hospital, Singapore